Ekocorp Plc - Cancellation of Proposed Annual General Meeting
Eye captured this official filing and document processing is still underway.
Please wait
Open
N/A
Previous close
N/A
Day range
N/A
Volume
0
Limited data
Awaiting filing
No current yield
65/100 measured
Liquidity unclear
The latest saved price history for EKOCORP, with its range and direction at a glance.
Eye captured this official filing and document processing is still underway.
EkoCorp Plc provides healthcare services in Nigeria. It provides outpatients nursing, capitation, intensive care unit, medical, pediatric, obstetrics and gynecology, radiology, surgery, and general services. It serves private, corporate, and health maintenance organizations. The company was formerly known as Eko Hospital Limited and changed its name to EkoCorp Plc in January 1995. EkoCorp Plc was founded in 1977 and is based in Lagos, Nigeria.
Investors usually follow EKOCORP for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
This official filing has been discovered and is awaiting full extraction or review.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
This official filing has been discovered and is awaiting full extraction or review.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Position: Director. Bought on 16 Feb 2021. From an official NGX Directors Dealings filing. Director dealing source fetched but no extractable text was found.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Director dealings
1
Reported buys, sells, and mixed dealings.
Official filings
10
Financial reports and company disclosures captured by Eye.
Market events
0
Insider, filing, dividend, and price events.
Source records
40
Captured updates we can trace.
Whisone is bearish because the bullish case is not yet strong enough to lead while fundamentals are weak at 41/100. Whisone has low conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
ROE
-19.1%
Return on equity
Debt / equity
0.20
Lower is usually safer.
74/100
Direction
Range-bound
Main supports
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Execution risk and market swings can still delay the forecast playing out.
Forecast refresh
Updated 10h ago
Quality score
48
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Sideways
+0.0% across the latest saved price window.
Volatility
N/A
Beta is not available for this stock.
52-week position
N/A
A complete 52-week range is not available.
Volume confirmation
N/A
Comparable volume data is not available.
local_manufacturing_and_access
EKOCORP may also move because the HEALTHCARE sector may benefit from local_manufacturing_and_access. Confidence 56%.
MeCure's emphasis on affordable, locally manufactured medicines and wider market penetration illustrates sector-level support for improved local manufacturing and access to quality medicines.
manufacturing infrastructure
EKOCORP may also move because the HEALTHCARE sector may benefit from manufacturing infrastructure. Confidence 56%.
Completion of a pharmaceutical manufacturing facility by Neimeth increases manufacturing capacity in the healthcare sector.
local_manufacturing_and_product_innovation
EKOCORP may also move because the HEALTHCARE sector may move with local_manufacturing_and_product_innovation. Confidence 53%.
MeCure's focus on deepening local manufacturing, product innovation, and expanded market penetration reflects sector-wide themes of local production and access to affordable medicines.
profit-taking
EKOCORP may also move because the HEALTHCARE sector may move with profit-taking. Confidence 53%.
Profit-taking is identified in the article as a trigger for the sell-off impacting SWOOT stocks.
increased manufacturing capacity
EKOCORP may also move because the HEALTHCARE sector may benefit from increased manufacturing capacity. Confidence 53%.
Neimeth's expansion and completion of a pharmaceutical manufacturing facility will increase production capacity within the healthcare sector.
Halal certification adoption
EKOCORP may also move because the HEALTHCARE sector may benefit from halal certification adoption. Confidence 49%.
Halal certification can increase consumer confidence and market access where Halal-compliant products are important, supporting sector trust and accessibility.
EKOCORP
Eko Corporation Plc
Price: ₦5.80
P/E: N/A
Yield: N/A
FIDSON
Fidson Healthcare Plc
Price: ₦93.55
P/E: 21.95
Yield: 1.5%
MAYBAKER
May & Baker Nigeria Plc
Price: ₦40.00
P/E: 14.36
Yield: 1.1%
MECURE
MeCure Industries Plc
Price: ₦56.20
P/E: 31.18
Yield: 0.6%
Industry
Miscellaneous Health And Allied Services, Not Elsewhere Classified
Exchange
NGX
Ticker
EKOCORP